We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRU
751
DELISTED
Crucible Acquisition Corporation
CRU
-1,072,868
Closed -$10.7M
PHIC
752
DELISTED
Population Health Investment Co., Inc. Class A Ordinary Share
PHIC
-1,678,317
Closed -$16.8M
SBII
753
DELISTED
Sandbridge X2 Corp.
SBII
-383,877
Closed -$3.77M
PHICU
754
DELISTED
Population Health Investment Co., Inc. Unit
PHICU
-2,670
Closed -$27K
SBII.U
755
DELISTED
Sandbridge X2 Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
SBII.U
-3,710
Closed -$36K
FRW
756
DELISTED
PWP Forward Acquisition Corp. I Class A Common Stock
FRW
-442,192
Closed -$4.34M
ASZ
757
DELISTED
Austerlitz Acquisition Corporation II
ASZ
-1,152
Closed -$11K
ASZ.U
758
DELISTED
Austerlitz Acquisition Corporation II Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
ASZ.U
-12,324
Closed -$121K
FVT
759
DELISTED
Fortress Value Acquisition Corp. III
FVT
-309,800
Closed -$3.07M
FVIV
760
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
-763,517
Closed -$7.51M
FLAC
761
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
-1,363,903
Closed -$13.6M
FVT.U
762
DELISTED
Fortress Value Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fifth of one Warrant
FVT.U
-141
Closed -$1K
ZEN
763
DELISTED
ZENDESK INC
ZEN
-1,195,332
Closed -$91M
IACC
764
DELISTED
ION Acquisition Corp 3 Ltd.
IACC
-143,910
Closed -$1.42M
TSPQ.WS
765
DELISTED
TCW Special Purpose Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TSPQ.WS
-18,600
Closed -$1K
ECOM
766
DELISTED
CHANNELADVISOR CORPORATION
ECOM
-924,487
Closed -$20.9M
AXH
767
DELISTED
Industrial Human Capital, Inc.
AXH
-13,267
Closed -$135K
NOAC
768
DELISTED
Natural Order Acquisition Corp. Common Stock
NOAC
-46,341
Closed -$462K
NOACU
769
DELISTED
Natural Order Acquisition Corp. Unit
NOACU
-10,555
Closed -$105K
HAAC
770
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
-801,176
Closed -$8M
HAACU
771
DELISTED
Health Assurance Acquisition Corp. SAIL Securities
HAACU
-3,157
Closed -$32K
CYBE
772
DELISTED
Cyberoptics Corp
CYBE
-144,834
Closed -$7.79M
BENE
773
DELISTED
Benessere Capital Acquisition Corp. Class A Common Stock
BENE
-1,026,262
Closed -$10.6M
HTAQ
774
DELISTED
Hunt Companies Acquisition Corp. I
HTAQ
-398,443
Closed -$4.04M
EDNC
775
DELISTED
Endurance Acquisition Corp. Class A Ordinary Shares
EDNC
-442,438
Closed -$4.43M

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.